Article
Multiple HLA-A alleles can present an immunodominant peptide of the human melanoma antigen Melan-A/MART-1 to a peptide-specific HLA-A*0201+ cytotoxic T cell line.
Journal of immunology (Baltimore, Md. : 1950) - 15 Jul 1996
Fleischhauer K, Tanzarella S, Wallny H J, Bordignon C, Traversari C
Abstract excerpt
The majority of HLA-A*0201-restricted tumor-infiltrating lymphocytes from melanoma patients recognize a peptide, MT(27-35), derived from the Melan-A/MART-1 Ag. This study reports that six variants of HLA-A2 and the HLA-A28 subtype A*6901 can present peptide MT(27-35). A CTL line specific for peptide MT(27-35) was generated by in vitro stimulation of PBL of an HLA-A*0201+, healthy donor with peptide-pulsed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.